GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2006

NCI Purchases Site License for Agilent Bioinformatics Solutions

  • The NCI purchased a full site license for a range of Agilent Technologies’ bioinformatics solutions, the company reports. Under the agreement, the NCI is making the following solutions available to its intramural program researchers: Agilent GeneSpring GX for gene expression, Agilent CGH Analytics for comparative genomic hybridization studies, Agilent Chip Analytics to analyze chromatin immunoprecipitation-on-chip data, and GeneSpring GT for genotyping and SNP analysis.

    The license, arranged under the auspices of the NCI's Office of Science and Technology Partnerships, will enable standardization of bioinformatics platforms so that users communicate using the same terms and share comparable training and support.

    Agilent GeneSpring GX 7.3 is designed to help researchers identify targets quickly and reliably. CGH Analytics 3.4 lets researchers visually explore, detect, and analyze aberration patterns from multiple CGH microarray profiles. It accepts data from Agilent feature extraction software and displays chromosomal deletions and amplifications and multiple zoom levels simultaneously.

    Agilent ChIP Analytics 1.2 lets users visually explore and analyze data from Agilent ChIP-on-chip microarrays. It accepts data from Agilent feature extraction software or AXON GenePix software, and analyzes the significance of protein-binding events without extensive processing or manipulation. GeneSpring GT 2.0 is a desktop analysis workbench for analyzing high-volume, high-density genotyping data.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »